Development of NLRP3-ASC selective inhibitors

Research unit

INNOSUISSE

Project number

38802.1 IP-LS

Project title

Development of NLRP3-ASC selective inhibitors

Texts for this project

	German	French	Italian	English
Short description		-	-
Abstract		-	-	-

Category	Text
Short description (German)	Development of NLRP3-ASC selective inhibitors
Short description (English)	Development of NLRP3-ASC selective inhibitors
Abstract (German)	Inhibition of the NLRP3 Inflammasome is a promising strategy to fight certain diseases with an (auto-)immune component, including gout, arthritis, Alzheimer's and Parkinson's. We will develop, optimize and validate one or several new NLRP3 inhibitors, starting from an existing set of lead molecules.